Clinical Features

Low Molecular Weight Heparin for treatment and prophylaxis of Venous Thromboembolism (VTE) during Pregnancy

Pulmonary embolism (PE) and deep vein thrombosis (DVT) are two components of a single condition called venous thromboembolism

venous thromboembolism

Introduction: Pulmonary embolism (PE) and deep vein thrombosis (DVT) are two components of a single condition called venous thromboembolism (VTE). In pregnancy although VTE is rare (1-2 per 1,000 pregnancies), it remains a leading cause of maternal death, as well as a source of maternal morbidity.

Risk factors for VTE can change during pregnancy, delivery and the postnatal period. A VTE can occur any time in all three trimesters of pregnancy, but the highest risk is in the 6 weeks immediately after birth.

For verified healthcare professionals

Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.

Register for free Log in

Join the conversation

Comments are open to registered members. Log in or register to share your thoughts on this article.

Log in to comment Register for free